​

Alaunos Therapeutics Ownership | Who Owns Alaunos Therapeutics?


OverviewForecastRevenueFinancialsChart

Alaunos Therapeutics Ownership Summary


Alaunos Therapeutics is owned by 6.98% institutional investors, 12.41% insiders, and 80.61% retail investors. Vanguard group is the largest institutional shareholder, holding 1.38% of TCRT shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.56% of its assets in Alaunos Therapeutics shares.

TCRT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAlaunos Therapeutics6.98%12.41%80.61%
SectorHealthcare Stocks 128.69%12.02%-40.72%
IndustryBiotech Stocks 180.58%11.62%-92.20%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group30.06K1.38%$97.10K
Blackrock funding, inc. /de21.35K0.88%$18.95K
Geode capital management19.29K0.79%$16.96K
Vanguard fiduciary trust15.50K0.64%$13.62K
Vanguard capital management14.06K0.58%$12.36K
Citadel advisors10.52K0.54%$30.08K
Tower research capital llc (trc)1.58K0.08%$4.53K
Advisor group1.67K0.07%$1.59K
Jones financial companies lllp1.33K0.05%$1.45K
Srs capital advisors1.22K0.05%$1.08K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tower research capital llc (trc)1.58K0.00%$4.53K
Cwm8.00-$23.00
Barclays---
Thurston, springer, miller, herd & titak---
Federation des caisses desjardins du quebec70.00-$200.00
Eversource wealth advisors135.00-$120.00
Nbc securities20.00-$18.00
Steward partners investment advisory112.00-$99.00
Advisor group1.67K-$1.59K
Geode capital management19.29K-$16.96K

Top Buyers

HolderShares% AssetsChange
Citadel advisors10.52K-10.52K
Vanguard group30.06K-9.09K
Jones financial companies lllp1.33K-1.33K
Tower research capital llc (trc)1.58K0.00%502.00
Morgan stanley1.20K-360.00

Top Sellers

HolderShares% AssetsChange
Hrt financial lp---13.33K
Two sigma investments, lp---10.84K
Xtx topco---10.17K
Ubs group67.00--925.00
Group one trading---300.00

New Positions

HolderShares% AssetsChangeValue
Citadel advisors10.52K-10.52K$30.08K
Jones financial companies lllp1.33K-1.33K$1.45K
Royal bank of canada185.00-185.00$1.00K
Eversource wealth advisors135.00-135.00$120.00
Cwm8.00-8.00$23.00

Sold Out

HolderChange
Wealthspire advisors-1.00
Truvestments capital-1.00
Citigroup-1.00
Psi advisors-6.00
Investment management corp /va/ /adv-6.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202627-10.00%169,64187.61%650.45%8-38.46%566.67%
Jun 30, 2026303.45%90,421-28.20%38.90%13-3-25.00%
Mar 31, 202616-38.46%32,877-69.71%16.83%5-37.50%2-66.67%
Dec 31, 20258-66.67%31,589-51.57%19.56%2-71.43%2-60.00%
Sep 30, 20255-80.77%21,173-70.16%16.43%1-83.33%--100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF24.91K1.56%-15.49K
Vanguard Total Stock Mkt Idx Inv17.35K1.08%-7.03K
Vanguard Institutional Extnd Mkt Idx Tr14.06K0.57%-
Fidelity Extended Market Index12.11K0.35%-
BlackRock Extended Equity Market K2.98K0.19%-2.00
Extended Equity Market Fund E3.42K0.15%-
Extended Equity Market Fund B3.42K0.15%-
Blackrock Extended Mkt Fund CF3.42K0.14%-
Extended Equity Market Fund K2.92K0.13%-21.00
BlackRock Extended Equity Market Fund K2.91K0.12%-5.00

Recent Insider Transactions


DateNameRoleActivityValue
Jun 24, 2025Vieser Jaime-Buy$1.12K
Jun 24, 2025Postma Robert W-Buy$2.69K
Apr 11, 2025Postma Robert W-Buy$1.38K
Dec 31, 2024Vieser Jaime-Sell$4.39K
Dec 31, 2024Vieser Jaime-Sell$1.64K

Insider Transactions Trends


DateBuySell
2026 Q4--
2026 Q3--
2026 Q2--
2026 Q1--
2025 Q4--

TCRT Ownership FAQ


Who Owns Alaunos Therapeutics?

Alaunos Therapeutics shareholders are primarily institutional investors at 6.98%, followed by 12.41% insiders and 80.61% retail investors. The average institutional ownership in Alaunos Therapeutics's industry, Biotech Stocks , is 180.58%, which Alaunos Therapeutics falls below.

Who owns the most shares of Alaunos Therapeutics?

Alaunos Therapeutics’s largest shareholders are Vanguard group (30.06K shares, 1.38%), Blackrock funding, inc. /de (21.35K shares, 0.88%), and Geode capital management (19.29K shares, 0.79%). Together, they hold 3.05% of Alaunos Therapeutics’s total shares outstanding.

Does Blackrock own Alaunos Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Alaunos Therapeutics.

Who is Alaunos Therapeutics’s biggest shareholder by percentage of total assets invested?

Tower research capital llc (trc) is Alaunos Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 1.58K Alaunos Therapeutics shares, valued at 4.53K$.

Who is the top mutual fund holder of Alaunos Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Alaunos Therapeutics shares, with 1.56% of its total shares outstanding invested in 24.91K Alaunos Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools